Your search
Results 37 resources
-
Summary. This detailed introduction not only outlines our approach in the book - including our use of client narratives and behavioral economics - it also includes a historical summary of housing policy in the U.S. over the past century and the evolution of the American Dream. We highlight stories of homeowners - mostly our clients -- and communities that have not recovered from the 2008 foreclosure crisis.
-
Summary. This book explores the systemic effects of public-private partnerships on public health. Focusing on partnerships involving the food and soda industries, the book argues that these relationships undermine public health and imperil the integrity of public health agencies, research universities, and public health NGOs. The default relationship with industry actors, the book argues, should be separation, not collaboration.
-
Summary. Asks what attitude and what policies democracies should have concerning individuals who give money away for public purposes; and argues that the aims of mass giving should be the decentralization of power in the production of public goods, such as the arts, education, and science
-
Summary. A summary of anti-corruption initiatives in Brazil.
-
Summary. Drug shortages and increasing generic drug prices are associated with low levels of competition. Mergers and acquisitions impact the level of competition. Record merger and acquisition activity was reported for the pharmaceutical sector in 2014/15, yet information on mergers and acquisitions in the generic drug sector are absent from the literature. This information is necessary to understand if and how such mergers and acquisitions can be a factor in drug shortages and increasing prices. METHODS: Data on completed merger and acquisition deals that had a generic drug company being taken over (i.e. 'target') were extracted from Bloomberg Finance L.P. The number and announced value of deals are presented globally, for the United States, and globally excluding the United States annually from 1995 to 2016 in United States dollars. RESULTS: Generic drug companies comprised 9.3% of the value of all deals with pharmaceutical targets occurring from 1995 to 2016. Globally, in 1995 there were no deals, in 2014 there were 22 deals worth $1.86 billion, in 2015 there were 34 deals totalling $33.56 billion, and in 2016 there were 42 deals worth in excess of $44 billion. This substantial increase was partially attributed to Teva's 2016 acquisition of Allergan's generic drug business. The surge in mergers and acquisitions for 2015/16 was driven by deals in the United States, where they represented 89.7% of the dollar value of deals in those years. CONCLUSIONS: The recent blitz in mergers and acquisitions signals that the generic drug industry is undergoing a transformation, especially in the United States. This restructuring can negatively affect the level of competition that might impact prices and shortages for some products, emphasizing the importance of updating regulations and procurement policies.
-
Summary. This book presents a comprehensive analysis of ownership and control of media providers today, and the affect that these ownership structures have on news sources and journalistic autonomy. Drawing on new research data, the book illustrates the essential themes and future directions for more democratic and accountable media systems in the 21st century.
-
Summary. Medusapp is a software for local governments that allows practical “open information” agreements between companies that present themselves to a public tender. In this way, not only governments assume the responsibility of opening information on public procurement processes but, in a voluntary and equitable manner, companies also commit to transparency.
-
Summary. Investigates strategies for regulating inappropriate faculty consulting relationships. This was my Safra project.
Explore
Resource type
- Book (12)
- Book Section (8)
- Conference Paper (1)
- Journal Article (14)
- Patent (1)
- Web Page (1)